Cargando…

TRAF Family Member-Associated NF-κB Activator (TANK) Induced by RANKL Negatively Regulates Osteoclasts Survival and Function

Osteoclasts are the principle bone-resorbing cells. Precise control of balanced osteoclast activity is indispensable for bone homeostasis. Osteoclast activation mediated by RANK-TRAF6 axis has been clearly identified. However, a negative regulation-machinery in osteoclast remains unclear. TRAF famil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Mengrui, Wang, Yiping, Deng, Lianfu, Chen, Wei, Li, Yi-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2012
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492797/ https://www.ncbi.nlm.nih.gov/pubmed/23139637 http://dx.doi.org/10.7150/ijbs.5079

Ejemplares similares

NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-κB and Reactive Oxygen Species Pathways
por: Kim, Jung Ha, et al.
Publicado: (2015)

TRAF6 neddylation drives inflammatory arthritis by increasing NF-κB activation
por: Liu, Kewei, et al.
Publicado: (2019)

TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
por: Walsh, Matthew C., et al.
Publicado: (2008)

The Scaffold Protein TANK/I-TRAF Inhibits NF-κB Activation by Recruiting Polo-like Kinase 1
por: Zhang, Wanqiao, et al.
Publicado: (2010)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
por: Zhou, Lin, et al.
Publicado: (2015)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017)

SHARPIN Negatively Associates with TRAF2-Mediated NFκB Activation
por: Liang, Yanhua
Publicado: (2011)

FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-κB Activation and CXCL10 Expression
por: Lv, Zheng-tao, et al.
Publicado: (2018)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
por: Wu, Lili, et al.
Publicado: (2019)

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling
por: Kim, Inyoung, et al.
Publicado: (2021)

Klotho upregulates the interaction between RANK and TRAF6 to facilitate RANKL-induced osteoclastogenesis via the NF-κB signaling pathway
por: Yu, Tao, et al.
Publicado: (2021)

Beneficial effect of pristimerin against the development of osteoporosis in ovariectomy-induced osteoporosis rats by the RANKL/TRAF6/NF-κB pathway
por: Xu, Wei, et al.
Publicado: (2019)

A Medium-Chain Fatty Acid, Capric Acid, Inhibits RANKL-Induced Osteoclast Differentiation via the Suppression of NF-κB Signaling and Blocks Cytoskeletal Organization and Survival in Mature Osteoclasts
por: Kim, Hyun-Ju, et al.
Publicado: (2014)

Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
por: Li, Shangfu, et al.
Publicado: (2016)

Natural Germacrane Sesquiterpenes Inhibit Osteoclast Formation, Bone Resorption, RANKL-Induced NF-κB Activation, and IκBα Degradation
por: Qin, Shengnan, et al.
Publicado: (2015)

Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways
por: Chen, Huiwen, et al.
Publicado: (2020)

C-Cbl negatively regulates TRAF6-mediated NF-κB activation by promoting K48-linked polyubiquitination of TRAF6
por: Jang, Hyun-Duk, et al.
Publicado: (2019)

Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2000)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
por: Yan, Liuliu, et al.
Publicado: (2019)

RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival
por: Fujiwara, T, et al.
Publicado: (2016)

Unkeito Suppresses RANKL-Mediated Osteoclastogenesis via the Blimp1–Bcl6 and NF-κB Signaling Pathways and Enhancing Osteoclast Apoptosis
por: Fang, Ke, et al.
Publicado: (2022)

BICP0 Negatively Regulates TRAF6-Mediated NF-κB and Interferon Activation by Promoting K48-Linked Polyubiquitination of TRAF6
por: Cao, Chong, et al.
Publicado: (2020)

Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling
por: Tomomura, Mineko, et al.
Publicado: (2015)

Polyphyllin VII attenuated RANKL-induced osteoclast differentiation via inhibiting of TRAF6/c-Src/PI3K pathway and ROS production
por: Zhou, Long, et al.
Publicado: (2020)

18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
por: Chen, Xiao, et al.
Publicado: (2018)

Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
por: Park, Gyeong Do, et al.
Publicado: (2021)

TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway
por: Li, Jian, et al.
Publicado: (2023)

Jun Dimerization Protein 2 (JDP2), a Member of the AP-1 Family of Transcription Factor, Mediates Osteoclast Differentiation Induced by RANKL
por: Kawaida, Reimi, et al.
Publicado: (2003)

TRAF2 is an NF-κB activating oncogene in epithelial cancers
por: Shen, Rhine R., et al.
Publicado: (2013)

MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
por: Liang, Jian, et al.
Publicado: (2010)

TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling
por: Espada, Constanza E., et al.
Publicado: (2021)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

NUMBL Interacts with TAK1, TRAF6 and NEMO to Negatively Regulate NF-κB Signaling During Osteoclastogenesis
por: Swarnkar, Gaurav, et al.
Publicado: (2017)

Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex
por: Min, Yoon, et al.
Publicado: (2017)

Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway In vitro and Protects Against Osteoporosis in Postmenopausal Mice
por: Chen, Yongjie, et al.
Publicado: (2022)

The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation
por: Thomas, Ranjeny
Publicado: (2005)

Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis
por: Kim, Nacksung, et al.
Publicado: (2005)

Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
por: Boyce, Brendan F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2jlp2p5sk1o2ss3mdusj9i02ho